Gambineri A, Forlani G, Munarini A, Tomassoni F, Cognigni G E, Ciampaglia W, Pagotto U, Walker B R, Pasquali R
Division of Endocrinology, Department of Internal Medicine, and Centre for Applied Biomedical Research (C.R.B.A.), S. Orsola-Malpighi Hospital, University Alma Mater Studiorum of Bologna, Bologna, Italy.
J Endocrinol Invest. 2009 Mar;32(3):210-8. doi: 10.1007/BF03346454.
Increased peripheral metabolism of cortisol may explain compensatory ACTH-dependent adrenal steroidogenesis and hence hyperandrogenism in polycystic ovary syndrome (PCOS). Previous studies have described an increased 5alpha-reduction of cortisol or impaired regeneration of cortisol by 11beta-HSD1 in PCOS. However, these observations may be confounded by obesity. Moreover, the relationship between alterations in cortisol metabolism and the extent of adrenal androgen hyper-secretion in response to ACTH has not been established. This study aimed to examine the association between cortisol metabolism and ACTH-dependent adrenal hyperandrogenism in PCOS, independently of obesity.
We compared 90 PCOS women (age 18-45 yr) stratified by adrenal androgen responses to ACTH1-24 and 45 controls matched for age and body weight.
PCOS women were stratified as normal responders (NR), intermediate responders (IR), and high responders (HR) to 250 microg ACTH1-24: NR (no.=27) had androstenedione and DHEA responses within 2 SD of the mean in controls; IR (no.=43) had DHEA responses >2 SD above controls; HR (no.=20) had both androstenedione and DHEA responses >2 SD above controls.
All groups were similar for age, body weight, and body fat distribution. Basal testosterone, androstenedione, and 5alpha-dihydrotestosterone plasma levels were similarly elevated among the 3 groups of PCOS compared with controls, whereas basal DHEA-S was higher in HR (2.8+/-1.2 microg/ml) and IR (2.4+/-1.1 microg/ml) than in NR (1.8+/-0.8 microg/ml) and controls (1.7+/-0.6 microg/ml). The HR group had the lowest basal plasma cortisol levels (101+/-36 ng/ml vs IR 135+/-42 ng/ml, NR 144+/-48 ng/ml, and controls 165+/-48 ng/ml; all p<0.01), but the greatest cortisol response to ACTH1-24 (Delta(60-0)cortisol 173+/-60 ng/ml vs IR 136+/-51 ng/ml, NR 114+/-50 ng/ml, and controls 127+/-50 ng/ml; all p<0.01), and the highest urinary excretion of total and 5beta-reduced cortisol metabolites (eg 5beta-tetrahydrocortisol/ cortisol ratio 25.2+/-15.3 vs IR 18.8+/-10.7, NR 19.7+/-11.4, and controls 17.2+/-13.7; all p<0.05). There were no differences in urinary excretion of 5alpha-reduced cortisol metabolites or in 5alpha-dihydrotestosterone/testosterone ratio between groups.
Adrenal androgen excess in PCOS is associated with increased inactivation of cortisol by 5beta-reductase that may lower cortisol blood levels and stimulate ACTH-dependent steroidogenesis.
皮质醇外周代谢增加可能解释多囊卵巢综合征(PCOS)中代偿性促肾上腺皮质激素(ACTH)依赖的肾上腺类固醇生成增加,进而导致高雄激素血症。既往研究描述了PCOS中皮质醇的5α-还原增加或11β-羟基类固醇脱氢酶1(11β-HSD1)对皮质醇的再生受损。然而,这些观察结果可能受到肥胖的干扰。此外,皮质醇代谢改变与ACTH刺激下肾上腺雄激素过度分泌程度之间的关系尚未明确。本研究旨在独立于肥胖因素,探讨PCOS中皮质醇代谢与ACTH依赖的肾上腺高雄激素血症之间的关联。
我们比较了90例PCOS女性(年龄18 - 45岁),根据对ACTH1-24的肾上腺雄激素反应进行分层,并与45例年龄和体重匹配的对照者进行比较。
PCOS女性根据对250μg ACTH1-24 的反应分为正常反应者(NR)、中度反应者(IR)和高度反应者(HR):NR(n = 27)组的雄烯二酮和脱氢表雄酮(DHEA)反应在对照者均值的2个标准差范围内;IR(n = 43)组的DHEA反应高于对照者均值2个标准差以上;HR(n = 20)组的雄烯二酮和DHEA反应均高于对照者均值2个标准差以上。
所有组在年龄、体重和体脂分布方面相似。与对照组相比,PCOS的3组患者基础睾酮、雄烯二酮和5α-双氢睾酮血浆水平均同样升高,而HR组(2.8±1.2μg/ml)和IR组(2.4±1.1μg/ml)基础硫酸脱氢表雄酮(DHEA-S)水平高于NR组(1.8±0.8μg/ml)和对照组(1.7±0.6μg/ml)。HR组基础血浆皮质醇水平最低(101±36ng/ml,IR组为135±42ng/ml,NR组为144±48ng/ml,对照组为165±48ng/ml;所有p<0.01),但对ACTH1-24的皮质醇反应最大(60-0分钟皮质醇变化量Δ(60-0)cortisol为173±60ng/ml,IR组为136±51ng/ml,NR组为114±50ng/ml,对照组为127±50ng/ml;所有p<0.01),且总皮质醇和5β-还原皮质醇代谢产物的尿排泄量最高(如5β-四氢皮质醇/皮质醇比值为25.2±15.3,IR组为18.8±10.7,NR组为19.7±11.4,对照组为17.2±13.7;所有p<0.05)。各组间5α-还原皮质醇代谢产物的尿排泄量或5α-双氢睾酮/睾酮比值无差异。
PCOS中肾上腺雄激素过多与5β-还原酶导致的皮质醇失活增加有关,这可能降低皮质醇血水平并刺激ACTH依赖的类固醇生成。